Rigel Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire
2025-05-06 • Google News
Rigel Pharmaceuticals Inc (RIGL)
US$ 19.363.42%
Price Chart
Key Statistics
Market Cap
$ 334.75M
P/E Ratio
8.96
Revenue (TTM)
$ 203.08M
Volume
110.74K
52W High
$ 29.82
52W Low
$ 7.48
Dividend Yield
0.00%
Beta
1.29
Technicals
50-Day MA
19.4176
200-Day MA
19.1154
52 Week High
29.82
52 Week Low
7.4843
About RIGL
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.
Employees
162
Headquarters
South San Francisco, CA
CEO
Mr. Raul R. Rodriguez
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg